PolyPeptide Group
PolyPeptide Group is a leading provider of custom/generic peptides for research and pharmaceutical applications with 6 facilities worldwide. Our focus is on proprietary and generic GMP-grade peptides for the pharmaceutical and biotechnological market. With more than 50 years of experience, we are committed to the highest quality of peptide manufacturing for every stage of product development.
PolyPeptide Group
PolyPeptide Group is a leading provider of custom/generic peptides for research and pharmaceutical applications with 6 facilities worldwide. Our focus is on proprietary and generic GMP-grade peptides for the pharmaceutical and biotechnological market. With more than 50 years of experience, we are committed to the highest quality of peptide manufacturing for every stage of product development.
Company name: PolyPeptide Group
Website: www.polypeptide.com
E-mail:
strasbourg@polypeptide.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
